Chinese companies fall back as Beijing denies loosening its anti-crypto stance.

The city-state has earmarked billions of dollars to develop capital-raising avenues.

Once a niche favorite among Hong Kong shoppers, the Argentine incense brand is expanding into China’s high-end malls.

Trust and prudence are central to Distinct Healthcare’s path to the public market.

The hog breeder plans to use the proceeds for R&D and overseas expansion, even as margins remain under pressure.

Bringing you the latest updates on funding and investment activity across the Asia Pacific.

The ODM plans to deploy IPO proceeds to parlay its capabilities into emerging categories, including smart glasses.

Mainland issuers and policy tailwinds helped HKEX eclipse Nasdaq and NYSE for the first time in years.